Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

285 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

3009 (91%)

3305

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

411 (94%)

Reversed:

23 (5%)

436

485 (13%)

40 (14%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-03-12 2020-08-27 108601
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-11-06 2021-01-07 128028
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2024-12-10 2025-04-24 245304
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144454
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-07-03 2026-03-12 261785
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-04-23 2020-08-27 113031
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144494
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144448
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144451
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144497
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-01-30 2025-04-24 249198
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-02-21 2020-04-09 106925
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-08-14 2026-03-12 265143
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2024-12-20 2026-03-12 246267
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-08-06 2020-11-07 121865
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Resolved 2017-08-01 2018-05-08 17779

Showing 3281 to 3300 of 3305

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
TEVA-LAMOTRIGINE 150MG TABLET Discontinued 2025-05-28 2025-05-28 258652
TEVA-LAMOTRIGINE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258646
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258510
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-25 2025-04-25 255824
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258507
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-29 2025-04-29 256085
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Discontinued 2025-05-28 2025-05-28 258625
TEVA-LISINOPRIL (TYPE P) 10MG TABLET Discontinued 2019-04-11 2019-04-11 81400
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
TEVA-LISINOPRIL (TYPE Z) 10MG TABLET Discontinued 2019-08-15 2019-08-15 91648
TEVA-LISINOPRIL (TYPE Z) 20MG TABLET Discontinued 2025-05-28 2025-05-28 258694
TEVA-LISINOPRIL (TYPE Z) 5MG TABLET Discontinued 2025-05-28 2025-05-28 258699
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368